Abstract: The present invention provides methods for preventing, attenuating neuronal damage or stimulating neuronal repair prior or following central nervous system injury.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FG-F21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: Described herein are aqueous organic redox flow batteries that include a first redox active material that can include a metallocene or a salt thereof, and a second redox active material that can include a viologen or a salt thereof. The aqueous organic redox flow batteries may further include a first aqueous electrolyte, a second aqueous electrolyte, and a separator between the first and second aqueous electrolytes. In addition, disclosed herein are methods of making the metallocene and viologen compounds.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to a network entity for managing communications of a plurality of communication devices within a communication network, a communication device of the plurality of communication devices being configured to transmit a multi-carrier communication signal comprising a plurality of sub-carriers, and to transmit an energy efficiency indicator indicating an energy efficiency specification of the communication device, the network entity comprising a communication interface being configured to receive the energy efficiency indicator over the communication network, and a processor being configured to determine a sub-carrier frequency spacing of the plurality of sub-carriers upon the basis of the energy efficiency indicator, and to generate a resource block indicator associated with the communication device, wherein the resource block indicator indicates the sub-carrier frequency spacing, wherein the communication interface is further configured to transmit the resource block indicator over the comm

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: Provided herein are glass based articles comprising SiO2, Al2O3, and two or more metal oxides selected from the group consisting of La2O3, BaO, Ta2O5, Y2O3, and HfO2. The glass based articles typically are characterized by a high fracture toughness (e.g., at least 0.86 MPa*m0.5), a high Young's modulus value (e.g., at least 85 GPa) and/or a stress optical coefficient (SOC) of not more than 3 Brewster (e.g., about 1.3 Brewster to about 2 Brewster). Also provided herein are glass based articles comprising SiO2 and two or more of MxOy, wherein M is Ba, La, Ta, Y, Al or Hf; wherein the total amount of SiO2 is the same or substantially the same as that of a reference glass based article comprising two or more binary compositions of MxOy—SiO2, wherein the reference glass based article has the same molar percentage of each MxOy, and the molar ratio of MxOy to SiO2 in each binary composition is 4/(c*x), wherein c is the number of charges of M.

Abstract: Compositions and methods for treatment and prevention of disorders and conditions characterized by reduced TGF-B signaling are described. In particular, the compositions and methods are useful for reducing or eliminating the pathologies associated with Alzheimer's disease. The compositions include urea derivatives containing a piperidine, piperidinium, or a piperidin-4-yl methyl; cycloalkyl, aryl, and fluorobenzyl moieties.

Abstract: The method includes that: when a first service has yet not ended before an original lifetime of a first IPv6 address terminates, a first terminal sends an address updating request message for querying about whether or not the first service supports IPv6 address updating to a second terminal; the first terminal receives an address updating response message returned by the second terminal; when a first determination result carried in the address updating response message indicates that the first service supports IPv6 address updating, the first terminal requests to establish a backup session for the first service with the second terminal by virtue of a second IPv6 address, which is pre-stored; and in the case that the first service has yet not ended when the original lifetime of the first IPv6 address terminates, the first terminal continues executing the first service with the second terminal by virtue of the backup session.

Abstract: Disclosed are novel methods for preventing or attenuating neuronal damage or stimulating neuronal repair, prior to or following central nervous system injury associated with acute or chronic nervous system injury. Macrophage colony stimulating factor receptor agonists including macrophage colony stimulating factor (M-CSF or CSF-1), interleukin-34 (IL-34), proteins or biologically active fragments thereof, peptides or biologically active fragments thereof, peptidomimetics, or small molecules, and the like are effective for prevention or treatment of acute nervous system injury or chronic nervous system injury involving Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and the like.

Abstract: A push-button on a device includes a shell of the device, an internal locking portion to connect with the device, a touch pole far away from the locking portion, and a supporting flange portion extending from the internal surface of the shell. The supporting flange portion and the device support each other. When the shell is pressed, the push-button elastically deforms as the locking portion 103 acts as a fixing point and the supporting end acts as a supporting point. The touch pole moves with the shell and the switch on a PCB is triggered to generate at least one signal.

Abstract: A spectrum manager for allocating a shared frequency spectrum in a wireless communication system is disclosed. The wireless communication system comprises a plurality of base stations which are operated by at least two operators, said spectrum manager being configured to group the plurality of base stations into clusters based on spectrum demand related information; and determine a spectrum partition pattern for each cluster based on the spectrum demand related information and information of the grouped based station clusters, a spectrum partition pattern specifying the partition and allocation of frequency spectrum fragments to said at least two operators in a corresponding cluster, wherein a frequency spectrum fragment is allocated to only one of said at least two operators in each cluster, and forward information regarding the spectrum partition pattern to the plurality of base stations or to one or a plurality of network entities of the at least two operators.

Abstract: A flexible circuit board includes a first base layer, a circuit layer, a second base layer and a bonding layer. The circuit layer is coupled to a side of the first base layer and includes a linear signal line, two grounding lines located at two opposite sides of the linear signal line, and two hollow areas located between the linear signal line and the grounding lines. The bonding layer couples the second base layer to the circuit layer and defines a first opening corresponding to the linear signal line and communicating with the hollow areas of the circuit layer. The first opening of the bonding layer and the hollow areas of the circuit layer cooperatively define an air medium layer surrounding the linear signal line. A method for manufacturing the flexible circuit board is also provided.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.

Abstract: The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.